Demonstration that cleavage of both APP and Notch are dependent on the product of the early onset Alzheimer's disease gene, presenilin-1 (PS1), has raised the possibility that Notch function may be altered in AD. This finding also suggests that Notch may be affected by APP␥-secretase inhibitors under development for the treatment of Alzheimer's disease, as these target PS1. Data that address these questions have been lacking, due to inability to specifically modulate PS1 activity in a system directly relevant to the adult human brain. Using novel highly specific inhibitors of PS1/␥-secretase, we demonstrate that modulation of PS1 activity in human CNS neurons not only affects A␤ generation, but also has unanticipated effects on Notch and its activity. We demonstrate that intracellular trafficking of Notch in human CNS neurons is altered by inhibition of PS1 and is accompanied by dramatic changes in neurite morphology, consistent with inhibition of Notch activity. These data, together with immunohistochemical evidence of elevation of Notch pathway expression in AD brain, suggest that Notch dysregulation may contribute to the neuritic dystrophy characteristically seen in Alzheimer's disease brain. In addition, they raise the possibility that inhibition of ␥-secretase/PS1 may have clinically beneficial effects on the neuritic pathology of AD, in addition to its expected effect to reduce amyloid burden.
INTRODUCTION
The defining pathologies of Alzheimer's disease are extracellular amyloid plaques composed primarily of fibrillar A␤ peptide, and intracellular neurofibrillary tangles containing hyperphosphorylated tau protein (Price et al., 1998) . In addition, regressive dendritic changes are prominent in the Alzheimer brain (Anderton et al., 1998) and are thought to contribute to symptomatology. Though much progress has been made in understanding the pathogenesis of amyloid and neurofibrillary pathologies (Selkoe, 1998) , the explanation for their co-occurrence remains controversial (Lee, 2001) , and the etiology of the Alzheimer dendritic pathology remains unclear. Abnormalities in Notch and/or Wnt signaling have been implicated in Alzheimer's disease by a number of recent findings, and suggest potential mechanisms by which generation of amyloid plaques, neurofibrillary tangles, and dystrophic neurons may be unified (Anderton et al., 2000) .
Notch activity is essential not only for a wide variety of cell fate determination events during development (Artavanis- Tsakonas et al., 1999) , but also serves important functions in the adult, particularly in the regulation of neurite outgrowth and maintenance (Redmond et al., 2000; Sestan et al., 1999; Wittenburg et al., 2000) and in hematopoiesis (Ellisen et al., 1991; Schroeder and Just, 2000) . Signaling through mammalian Notch has been shown to require three separate proteolytic events: first, a constitutive furin-like cleavage within the endoplasmic reticulum/Golgi (Blaumueller et al., 1997; Logeat et al., 1998) , followed by transport of the cleavage products as a heterodimer to the cell surface; and ligand-dependent cleavages by TACE in the extracellular domain (Brou et al., 2000; Mumm et al., 2000) and PS1 within the transmembrane domain (De Strooper et al., 1999; Herreman et al., 2000;  
